Perspective Therapeutics Inc. Earnings
The next earnings date for Perspective Therapeutics Inc. is November 18, 2025.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of Perspective Therapeutics Inc. Earnings
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Perspective Therapeutics Inc. Earnings: Historical
More About Perspective Therapeutics Inc.
Perspective Therapeutics, Inc., together with its subsidiaries, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. The company discovers, and develop its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta emitting therapy; VMT01, which is in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma; PSV359, a targeted alpha therapy targeting fibroblast activation protein alpha; and PSV4XX, a differentiated prostate-specific membrane antigen-targeted alpha therapy. It has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 2004 and is headquartered in Seattle, Washington.
“Perspective Therapeutics Inc. Earnings” Can Refer to the Perspective Therapeutics Inc. Earnings Date
Some people say “Perspective Therapeutics Inc. earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Perspective Therapeutics Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Perspective Therapeutics Inc. Stock on the Earnings Date
If you own Perspective Therapeutics Inc. stock (CATX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Perspective Therapeutics Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Perspective Therapeutics Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Perspective Therapeutics Inc. Earnings
You can contact us any time if you would like to ask questions about Perspective Therapeutics Inc. earnings or anything else related to the stock market.